Pathological anti-β2-glycoprotein I antibodies disrupt the anticoagulant activity of annexin A5:: A possible explanation for the lupus anticoagulant paradox.

被引：0
|
作者：
de Laat, B
Wu, XX
van Lummel, M
Derksen, RHWM
de Groot, PG
Rand, JH
机构：
[1] Univ Utrecht, Med Ctr, Utrecht, Netherlands
[2] Albert Einstein Coll Med, Montefiore Med Ctr, New York, NY USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
135
引用
收藏
页码：43A / 43A
页数：1
相关论文
共 50 条
  • [1] Procoagulant effect of anti-β2-glycoprotein I antibodies with lupus anticoagulant activity
    Pengo, V
    Brocco, T
    Biasiolo, A
    Rampazzo, P
    Carraro, P
    Zamarchi, R
    BLOOD, 1999, 94 (11) : 3814 - 3819
  • [2] Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I
    Wahezi, D. M.
    Ilowite, N. T.
    Wu, X. X.
    Pelkmans, L.
    Laat, B.
    Schanberg, L. E.
    Rand, J. H.
    LUPUS, 2013, 22 (07) : 702 - 711
  • [3] Anti-β2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant
    Sailer, Thomas
    Zoghlami, Claudia
    Kurz, Christine
    Rumpold, Helmut
    Quehenberger, Peter
    Panzer, Simon
    Pabinger, Ingrid
    THROMBOSIS AND HAEMOSTASIS, 2006, 95 (05) : 796 - 801
  • [4] Correlation between antiphospholipid antibodies that recognize domain I of β2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5
    de Laat, Bas
    Wu, Xiao-Xuan
    van Lummel, Menno
    Derksen, Ronald H. W. M.
    de Groot, Philip G.
    Rand, Jacob H.
    BLOOD, 2007, 109 (04) : 1490 - 1494
  • [5] Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-β2-glycoprotein I and anti-annexin A5 antibodies
    Gaspersic, N.
    Ambrozic, A.
    Bozic, B.
    Majhenc, J.
    Svetina, S.
    Rozman, B.
    RHEUMATOLOGY, 2007, 46 (01) : 81 - 86
  • [6] The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-β2-glycoprotein I antibodies
    Neville, C.
    Rauch, J.
    Kassis, J.
    Solymoss, S.
    Joseph, L.
    Belisle, P.
    Subang, R.
    Chang, E. R.
    Fortin, P. R.
    RHEUMATOLOGY, 2006, 45 (09) : 1116 - 1120
  • [7] Inhibition of APC anticoagulant activity on oxidized phospholipid by anti-β2-glycoprotein I monoclonal antibodies
    Safa, O
    Esmon, CT
    Esmon, NL
    BLOOD, 2005, 106 (05) : 1629 - 1635
  • [8] Anti-β2-glycoprotein I and anti-prothrombin antibodies cause lupus anticoagulant through different mechanisms of action
    Noordermeer, Tessa
    Molhoek, Jessica E.
    Schutgens, Roger E. G.
    Sebastian, Silvie A. E.
    Drost-Verhoef, Sandra
    van Wesel, Annet C. W.
    de Groot, Philip G.
    Meijers, Joost C. M.
    Urbanus, Rolf T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (04) : 1018 - 1028
  • [9] Differential effects of anti-β2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C
    Galli, M
    Ruggeri, L
    Barbui, T
    BLOOD, 1998, 91 (06) : 1999 - 2004
  • [10] Lupus anticoagulant and antibodies to β2-glycoprotein I, annexin V, and cardiolipin as a cause of recurrent spontaneous abortion
    Mtiraoui, N.
    Zammiti, W.
    Fekih, M.
    Hider, S.
    Almawi, W. Y.
    Mahjoub, T.
    FERTILITY AND STERILITY, 2007, 88 (05) : 1458 - 1461
12345